Isolation, Identification and Determination of the Prevalence of Mycobacterium tuberculosis Complex among People Living with HIV in Kisumu County, Kenya
Science Journal of Public Health
Volume 4, Issue 4, July 2016, Pages: 359-365
Received: Jun. 15, 2016; Accepted: Jul. 12, 2016; Published: Jul. 28, 2016
Views 3412      Downloads 70
Authors
Maryanne Betsy Usagi, Department of Microbiology, School of Science, Kenyatta University, Nairobi, Kenya
Gilbert Abura Odilla, Department of Education, Faculty of Education and Resources Development, Chuka University, Chuka, Kenya
John Muthini Maingi, Department of Microbiology, School of Science, Kenyatta University, Nairobi, Kenya
Anthony Kebira, Department of Microbiology, School of Science, Kenyatta University, Nairobi, Kenya
Article Tools
Follow on us
Abstract
Mycobacterium tuberculosis complex are important pathogens to man and causative agents of tuberculosis. Tuberculosis is one of the diseases that continue to be a public health concern in the world. Earlier, tuberculosis was considered controlled, but with emergence of HIV and AIDS, the disease has been exacerbated, with the highest incidences being in sub-Saharan Africa. Kenya ranks 15th and 5th in the World and Africa respectively. The World Health Organization indicates that there were 300 TB cases per 100,000 people in 2011. Information on the identity of the Mycobacterium tuberculosis complex and the prevalence of pulmonary tuberculosis in HIV positive patients seeking treatment in Kisumu County is limited. In this study, we isolated and identified the Mycobacterium tuberculosis complex and also determined the prevalence of tuberculosis in HIV patients seeking treatment in Kisumu County. A cross-sectional study was conducted between December 2013 and June 2014. The study engaged, 379 HIV positive patients suspected of TB infection who gave sputum samples. The sputum samples were then decontaminated, concentrated, liquefied and neutralized before being cultured in liquid media using MGIT 960 tubes. The culture positive MGIT tubes were sub cultured in Brain Heart Infusion Agar (BHIA) before microscopic examination of the culture using ZN smear for Acid Fast Bacilli and identified using Genotype MTBC. In the study, 130 (34.3%) of the 379 suspected TB patients were diagnosed positive for pulmonary TB by MGIT culture. A significantly greater number of males were diagnosed with pulmonary tuberculosis compared to females (57.7% and 42.3% respectively; χ 2 = 1.0342, df = 1 P < 0.05). Further, the study revealed that TB prevalence decreased steadily with age, with the youths being at greater risk of becoming active patients. In the age category of 26-35 years, prevalence was 36.92% while, for age category above 55 years it was 6.15%. Based on the results, the etiological agent of tuberculosis in Kisumu County is Mycobacterium tuberculosis, the prevalence of infection was higher in males than in females and the prevalence rate to infection was highest among the youth. There is need for rapid and accurate diagnosis of active TB particularly in HIV-positive patients. Also, TB awareness and control programme should mainly be directed towards the youths by the all the stakeholders in the Public Health sector.
Keywords
Determination, Mycobacterium Tuberculosis Complex, Isolation, Identification, Prevalence
To cite this article
Maryanne Betsy Usagi, Gilbert Abura Odilla, John Muthini Maingi, Anthony Kebira, Isolation, Identification and Determination of the Prevalence of Mycobacterium tuberculosis Complex among People Living with HIV in Kisumu County, Kenya, Science Journal of Public Health. Vol. 4, No. 4, 2016, pp. 359-365. doi: 10.11648/j.sjph.20160404.24
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Adane, K., Ameni, G., Bekele, S., Abede, M. and Aseffa, A. (2015). Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, Northwest Ethiopia. Biomed Central Public Health, 15: 1933-1939.
[2]
Jean-Paul Assam-Assam 1, Veronique B Penlap, Fidelis Cho-Ngwa 1, Jean-Claude Tedom, Irene Ane-Anyangwe 1 and Vincent P Titanji. (2011). Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. Biomed Central Public Health, 1471-2334-11-94
[3]
Asiimwe, B. B., Koivula, T., Källenius, G., Huard, R. C., Ghebremichael, S. Asiimwe, J. and Joloba, M. L. (2008). Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda. International Journal of Tuberculosis and Lung Disease, 12 (4): 386-91
[4]
Brooks, G. F., Carrol, C. K., Butel, J. S. and Morse, S. A. (2007). Medical microbiology 24th ed. McGraw Hill, New York.
[5]
Chakaya, J. M. (2005). National Leprosy and Tuberculosis Programme. What the health worker needs to know. Nairobi, Government printers.
[6]
Fisher, A. A., Liang, J. E., Stoeckel, J. E and Townsend J. J. (1998). Hand book for family planning operations research designs 2nd ed. Population council, New York USA.
[7]
Grange, J. M., Malcolm, D. Y. and Kantor I. N., (1996). Guidelines for speciation within the Mycobacterium tuberculosis complex 2nd ed. WHO. Available on line (http://whqlibdoc.who.int/hq/1996/WHO EMC ZOO 96pdf). Accessed August 2014.
[8]
Lonnroth, K., Juramillo, E., Williams, B., Dye, C., Raviglione, M. (2009). Drivers of tuberculosis epidemics. The role of risk factors and social determinants. International Journal of Tuberculosis and Lung Diseases 8: 245- 357.http://www.sciencedirect.com/science/article/pii/SO2777953609002111. Accessed August 2014.
[9]
Ministry of Health. (2010). National Leprosy Tuberculosis annual report. Government Printers, Nairobi.
[10]
Ministry of Health of Kenya (MoH) (2005). National Leprosy Tuberculosis Programme. TB management guidelines. Government printers, Nairobi.
[11]
Ministry of Health (MoH) (2003). National Leprosy Tuberculosis Programme. Annual report. Government printers, Nairobi.
[12]
Ministry of health and family welfare (2009). Mycobacterium tuberculosis culture and drug susceptibility testing report. Government of India.
[13]
Ministry of Public Health and Sanitation. (2012). TB Control. Government Printers. Nairobi.
[14]
National AIDS and STI control Programme (NASCOP) Kenya (2014). Kenya AIDS Indicator Survey: Final Report. Nairobi, NASCOP.
[15]
Ndung’u, P., Kariuki, S., Ng’ang’a, Z. and Revathi, G. (2012). Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi. Journal of Infection in Developing Countries, 6 (1): 33-39
[16]
Niemann, S., Kubica, T., Bange, F. C., Adjei, O., Brown, E. N., Chinbuah, M. A., Diel, R., Gyapong, J., Horstmnn, R. D, Joloba, M. L., Meyer, C. G., Mugerwa, R. D., Okerwa, A., Osei, I., Owusu-Darbo, E., Schwander, S. K. and Rusch- Gerdes, S. (2004). The species of Mycobacterium africanum in the light of new molecular markers. Journal of Clinical Microbiology. 42 (9) 3958-3662.
[17]
Nyangau, L. O., Amukoye, E. and Ng’ang’a, Z. (2015). Determining fist line anti- tuberculosis drug resistance among new and re-treatment tuberculosis HIV infected patients, Nairobi Kenya. International Journal of Sciences, 19: (20) 426-437.
[18]
Peeling, R. (2008). Tuberculosis Diagnostics evaluation 2 TDR Research publications 81. Available on line (www.who.int/tdr/svc/publication/tdr-research.) Accessed June 2014.
[19]
Rajeswari, R., Chandrasekaran, V., Suhedev, M., Sivasubramaniam, S., Sudha, G. and Rehu, G. (2002). Factors associated with patient and health system delays in diagnosis of tuberculosis in South India. International Journal of Tuberculosis and Lung Disease. 6: 789-795.
[20]
Sanchez-Padilla, E., Ardizzoni, E., Sauvageot, D., Ahoua, L., Martin, A., Varaine, F., Adatu-Engwau, F., Akeche, G., Salaniponi, F. and Bonnet, M. (2013). Multidrug and Isoniazid resistant tuberculosis in three high HIV burden African regions. International Journal of Tuberculosis and Lung Diseases. 17 (8): 1036-1042.
[21]
Shinghal N., Prashant, S., Manish, K., Beenu J. and Deepa B. (2012). Analysis of intracellular Expressed Proteins of Mycobacterium tuberculosis Clinical Isolates. Proteome Science 10: 1186/1477-5956-10-14. Available on line (http:/www.proteomesci.com/content/10/1/14). Accessed July 2024.
[22]
Siddiqi, S. H and Rusch-Gerdes, S. (2006). MGIT Procedure Manual. Foundation for Innovative new diagnostics. Available on line (http://www.finddiagnostics.org/export/..../pdfs/mgit-manual-nov.2006.pdf)
[23]
World Health Organization (2015). Global Tuberculosis Report. 20th Edition. Geneva.
[24]
World Health Organization (2013). Global TB Report. TB/HIV fact sheet No. 104 Revised, Geneva.
[25]
World Health Organization (2012). Tuberculosis Diagnostic Technology Landscape. Available on line (www.unitaid@who.int.) accessed March 2015.
[26]
World Health Organization (2005). TB/HIV Fact Sheet No. 104. Geneva.
[27]
World Health Organization (2004). Interim Policy on Collaborative TB/HIV Activities. WHO/HTM/TB/2004.330 and WHO/HIV/2004.01.2004.
[28]
World Health Organization (2004). TB/HIV: A Clinical Manual 2nd ed. Geneva.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186